Tempus ECG-Low EF vs OMRON VitalSight
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your healthcare facility needs an AI-powered solution to efficiently screen for signs of low left ventricular ejection fraction (LVEF) in patients aged 40 or older during routine 12-lead ECG analysis. This tool is ideal for aiding clinicians in identifying at-risk individuals for heart failure who may require further diagnostic evaluation, streamlining early detection within existing clinical workflows.
View Tempus ECG-Low EF →Choose OMRON VitalSight if…
Choose OMRON VitalSight if you are a US physician seeking a comprehensive remote patient monitoring service to effectively manage hypertension in your patient population. This solution provides pre-set, connected blood pressure monitors for at-home use, securely integrating data into EHRs and offering automatic notifications for out-of-range readings to improve patient outcomes and facilitate reimbursement.
View OMRON VitalSight →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | OMRON VitalSight |
|---|---|---|
| Pricing | Unknown | Reimbursement-based |
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | Cloud-based (physician dashboard) with at-home patient devices. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
OMRON VitalSightOMRON VitalSight provides pre-set devices that operate without Wi-Fi or cellular connection, delivered directly to the patient's home, simplifying the patient experience. Its physician dashboard and EHR integration also streamline clinical workflows. While Tempus ECG-Low EF integrates into existing facility workflows, VitalSight's comprehensive approach to remote monitoring, including patient-side ease of use, gives it an edge in overall usability for its intended purpose.
Clinical Value
TieBoth tools offer significant and distinct clinical value. Tempus ECG-Low EF aids in early detection of low LVEF from standard ECGs, potentially identifying patients at risk for heart failure who might otherwise be missed. OMRON VitalSight provides continuous remote monitoring for hypertension, enabling proactive management and improved outcomes for a prevalent chronic condition. Both are FDA-cleared and address critical needs in cardiovascular care.
Pricing & Value
OMRON VitalSightOMRON VitalSight offers a transparent, reimbursement-based pricing model, with Medicare reimbursement and generally little to no cost for patients or physicians, including no setup or device costs. Tempus ECG-Low EF requires contacting the vendor for pricing, which suggests less transparency and potentially higher or less predictable costs for healthcare facilities.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering Business Associate Agreements (BAAs). Tempus ECG-Low EF integrates into existing healthcare facility workflows, while OMRON VitalSight offers EHR/EMR integration and a cloud-based physician dashboard. Both are designed for secure and compliant deployment within healthcare systems.
Innovation
Tempus ECG-Low EFTempus ECG-Low EF represents a significant innovation by using AI to extract novel, clinically actionable insights (detection of low LVEF) from widely available, standard 12-lead ECGs. This transforms an existing diagnostic test into a powerful screening tool. While OMRON VitalSight innovates in simplifying remote patient monitoring, the core application of AI for hidden ECG insights is a more groundbreaking advancement.
Support & Docs
OMRON VitalSightOMRON VitalSight provides readily accessible support resources, including user guides, FAQs, and clear contact information for both physicians and patients. Tempus AI offers general customer support contact information, but specific documentation or tiered support details for ECG-Low EF are less transparently available online.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | OMRON VitalSight |
|---|---|---|
| Tool Name | Tempus ECG-Low EF | OMRON VitalSight |
| Company | Tempus AI | OMRON Healthcare |
| Primary Focus/Condition | Detects signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients at risk of heart failure | Remote patient monitoring for hypertension management |
| Data Input/Source | 12-lead ECG recordings | Remote blood pressure readings from connected blood pressure monitors |
| Output/Functionality | Binary output (Low LVEF Detected / Not Detected) to aid clinicians in further evaluation | Secure, digital data sharing with EHR/EMR integration or VitalSight Dashboard access; automatic notifications for out-of-range readings |
| Target Patient Population | Patients 40 years or older at risk of heart failure | Patients managing hypertension |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and OMRON VitalSight.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or OMRON VitalSight
Backers
Who funded each tool's parent company.